This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Predicting risk of osteoporotic fracture

Authoring team

A risk prediction utility to identify accurately the individuals at high risk of osteoporotic fracture who might benefit from a therapeutic or preventive intervention has been a necessity since identifying people at high risk will help in reducing the morbidity associated with osteoporotic fractures (1)

  • several guidelines recommend an approach which identifies high risk patients who are likely to benefit from interventions based on a 10 year absolute fracture risk (1).

The traditionally used approach has been to use the bone mineral density (BMD) measurements

  • this method is not suitable for population screening due to the cost and low sensitivity
  • most fractures are seen in women with normal BMD
  • it has been shown that risk prediction algorithms that do not include BMD are almost as good as those that include BMD

Risk prediction algorithms tend to perform best when they are developed in a clinical setting in which they will be applied (1).

Available fracture risk assessment tools include:

  • WHO risk calculator (FRAX)
  • QFracture score (1)

Reference:

  • 1. International Osteoporosis Foundation and National Osteoporosis Foundation 2011. Osteoporosis: burden, health care provision and opportunities in the EU. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.